Millendo Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch MLND and buy or sell other stocks, ETFs, and their options commission-free!About MLND
Tempest Therapeutics, Inc. is a clinical-stage oncology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a wide range of tumors. The company’s novel programs range from early research to later-stage investigation in a randomized global study in first-line cancer patients.
CEOStephen R. Brady
CEOStephen R. Brady
Employees25
Employees25
HeadquartersBrisbane, California
HeadquartersBrisbane, California
Founded2011
Founded2011
Employees25
Employees25
MLND Key Statistics
Market cap18.34M
Market cap18.34M
Price-Earnings ratio-0.31
Price-Earnings ratio-0.31
Dividend yield—
Dividend yield—
Average volume303.47K
Average volume303.47K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$13.65
52 Week high$13.65
52 Week low$3.00
52 Week low$3.00
Stock Snapshot
With a market cap of 18.34M, Millendo Therapeutics(MLND) trades at $4.13. The stock has a price-to-earnings ratio of -0.31.
During the trading day, Millendo Therapeutics(MLND) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 303.47K.
Over the past 52 weeks, Millendo Therapeutics(MLND) stock has traded between a high of $13.65 and a low of $3.00.
Over the past 52 weeks, Millendo Therapeutics(MLND) stock has traded between a high of $13.65 and a low of $3.00.
People also own
Based on the portfolios of people who own MLND. This list is generated using Robinhood data, and it’s not a recommendation.